HCPCS Level II code Q1005 designates a Category 5 new-technology intraocular lens approved via Federal Register guidance. The code enables distinct identification of novel intraocular lens products used during cataract surgery or related ophthalmic procedures and supports payers and providers in tracking utilization, coverage determinations, and payment policy for emerging lens technologies. Nationally, an explicit HCPCS Level II code matters for claims processing, coverage policies, and manufacturer reporting for novel devices entering the market.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical context, typical service settings, and what to expect in payer coverage approaches. The publication outlines common modifiers associated with device and procedure billing (listed separately), discusses how payers may address new-technology lens claims, and highlights benchmarking and policy considerations relevant to national coverage and reimbursement. This resource is intended to inform billing staff, policy analysts, and revenue managers about the role of Q1005 in claims workflows and payer communications.

Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and service-line specifics beyond the description provided.